LCN2 and brain ischemia: In a variety of CNS injuries (e.g., cerebral ischemia, cerebral hemorrhage, traumatic brain injury, etc.), reactive astrocytes characteristically express LCN2, which can therefore be used as a marker of reactive astrocytes for assessing the extent and prognosis of CNS injury (Liu et al., 2022).